Pneumonia and procalcitonin levels: refining outcome prediction

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Serial procalcitonin (PCT) measurement in patients with pneumonia shows promise for predicting adverse clinical outcomes.

Why this matters

  • Largest study in North America evaluating prognostic potential of serial PCT in hospitalized patients with community acquired (CAP) or hea...